1. Home
  2. PLUR vs UG Comparison

PLUR vs UG Comparison

Compare PLUR & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$3.03

Market Cap

28.4M

Sector

Health Care

ML Signal

HOLD

Logo United-Guardian Inc.

UG

United-Guardian Inc.

N/A

Current Price

$6.62

Market Cap

27.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
PLUR
UG
Founded
2001
1942
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
28.4M
27.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PLUR
UG
Price
$3.03
$6.62
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
20.6K
11.4K
Earning Date
02-10-2026
11-06-2025
Dividend Yield
N/A
10.90%
EPS Growth
N/A
N/A
EPS
N/A
0.43
Revenue
$1,326,000.00
$10,060,322.00
Revenue This Year
$97.38
N/A
Revenue Next Year
$293.97
N/A
P/E Ratio
N/A
$15.05
Revenue Growth
121.74
N/A
52 Week Low
$2.82
$5.58
52 Week High
$7.13
$11.98

Technical Indicators

Market Signals
Indicator
PLUR
UG
Relative Strength Index (RSI) 44.55 62.27
Support Level $3.01 $6.16
Resistance Level $3.21 $6.74
Average True Range (ATR) 0.15 0.13
MACD 0.03 0.05
Stochastic Oscillator 33.15 72.66

Price Performance

Historical Comparison
PLUR
UG

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

Share on Social Networks: